abaloparatide bone
Selected indexed studies
- Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. (Ann Intern Med, 2023) [PMID:36592455]
- The clinician's guide to prevention and treatment of osteoporosis. (Osteoporos Int, 2022) [PMID:35478046]
- Osteoporosis: A Review. (JAMA, 2025) [PMID:40587168]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial. (2016) pubmed
- Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis. (2025) pubmed
- The clinician's guide to prevention and treatment of osteoporosis. (2022) pubmed
- Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. (2023) pubmed
- Osteoporosis: A Review. (2025) pubmed
- Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide. (2025) pubmed
- Effects of Abaloparatide on Bone Mineral Density in Proximal Femoral Regions Corresponding to Arthroplasty Gruen Zones: A Study of Postmenopausal Women with Osteoporosis. (2024) pubmed
- Abaloparatide increases bone mass without affecting growth of bone-disseminated cancer cells. (2025) pubmed
- Drug therapy for osteoporosis in older adults. (2022) pubmed
- Local abaloparatide administration promotes in situ alveolar bone augmentation via FAK-mediated periosteal osteogenesis. (2025) pubmed